Concepedia

Lily Y. Moy

LY

Statistics

Publications

29

Citations

1.9K

H-Index

20

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Massachusetts Institute of Technology

Howard Hughes Medical Institute

Harvard University

Lily Y. Moy is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, life sciences, and pharmacy.

ORCID

Publications per year

1994–2024

29

Publications

29

Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity

Dohoon Kim, Christopher L. Frank, Matthew M. Dobbin et al. · Neuron · 2008 · 291 citations · Full text

, , +9

Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma

Handan Xiang, Carlo P. Ramil, Josephine Hai et al. · Cancer Immunology Research · 2020 · 265 citations · Full text

, , +17

p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid β<i>In Vivo</i>

Jonathan C. Cruz, Do‐Hoon Kim, Lily Y. Moy et al. · Journal of Neuroscience · 2006 · 203 citations · Full text

, , +17

Cep120 and TACCs Control Interkinetic Nuclear Migration and the Neural Progenitor Pool

Zhigang Xie, Lily Y. Moy, Kamon Sanada et al. · Neuron · 2007 · 182 citations · Full text

, , +10

Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment

Martin R. Gluck, Lily Y. Moy, Elizabeth Jayatilleke et al. · Journal of Neurochemistry · 2001 · 152 citations · Full text

, , +17

1–5 of 29